Publications in collaboration with researchers from University of Montreal (9)

2022

  1. Biallelic ELMO3 mutations and loss of function for DOCK-mediated RAC1 activation result in intellectual disability

    Small GTPases, Vol. 13, Núm. 1, pp. 48-55

2021

  1. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    npj Breast Cancer, Vol. 7, Núm. 1

2020

  1. Effect of platelet storage duration on clinical outcomes and incremental platelet change in critically ill children

    Transfusion, Vol. 60, Núm. 12, pp. 2849-2858

2016

  1. Subgroup analyses from a phase 3, open-label, randomized study of eribulin mesylate versus capecitabine in pretreated patients with advanced or metastatic breast cancer

    Breast Cancer: Basic and Clinical Research, Vol. 10, pp. 77-84

2015

  1. "New" metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy

    Breast Cancer Research, Vol. 17, Núm. 1

  2. Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial

    Breast Cancer Research and Treatment, Vol. 154, Núm. 3, pp. 509-520

  3. Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane

    Journal of Clinical Oncology, Vol. 33, Núm. 6, pp. 594-601

  4. Vólvulos del tracto gastrointestinal. Diagnóstico y correlación entre radiología simple y tomografía computarizada multidetector

    Radiologia, Vol. 57, Núm. 1, pp. 35-43

1991

  1. ROLE OF OXYGEN RESTORATION IN REPERFUSION-INDUCED ARRHYTHMIAS - DIFFERENTIAL-EFFECTS ON VENTRICULAR ECTOPIC ACTIVITY AND VENTRICULAR-FIBRILLATION IN THE PIG

    JOURNAL OF APPLIED CARDIOLOGY, Vol. 6, Núm. 6, pp. 411-420